mRNA-based vaccines

mRNA
#Drug discovery #eBook #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines

Discover mRNA: Beyond vaccines to personalised medicine

Despite a challenging funding landscape, 2026 has seen two groundbreaking advances in mRNA vaccine discovery; the first-ever mRNA seasonal influenza vaccine for adults and the first positive Phase III readout for an mRNA-based cancer therapy. This eBook explores how the mRNA platform has evolved since its use in Covid-19 vaccines,… Read More

#News

RNA vaccine
#Immunology / Virology & Vaccines #Influenza #mRNA #mRNA-based vaccines

mRNA vaccine produces more diversified antibody response

A new study has revealed how an mRNA-based influenza vaccine reshapes immune responses at the cellular and molecular levels.   By tracking germinal-centre (GC) activity and individual secreted antibody clonotypes for up to six months, researchers uncovered how vaccination drives the evolution and diversification of immune responses.  … Read More

#News

Flu vaccine
#GSK #Immunology / Virology & Vaccines #Influenza #mRNA #mRNA-based vaccines

GSK reveals plans to advance mRNA flu vaccine to Phase III

GSK has revealed that its mRNA seasonal influenza (flu) vaccine candidate has shown higher immune responses against all influenza strains tested compared to licensed standard dose and high dose inactivated flu vaccines.  The Phase II data were presented at the OPTIONS XIII Conference for the Control of… Read More

#News

#Biomedical research #Biotechnology #Drug discovery #Heart disease #mRNA-based vaccines

This week in Drug Discovery (13 – 17 July) 

News round-up for 13 – 17 July by Bruno Quinney, Content Team at DDW.  This week, a new drug has shown potential to treat heart disease. Elsewhere, Cancer Research UK is leading a global cancer trial.  The top stories:  New drug could treat common heart disease, study… Read More

#News

Bacteria in Petri dishes
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Covid-19 #mRNA #mRNA-based vaccines #Oncology #RNA

How drug discovery is tackling global health challenges

This is the latest episode of the free DDW Narrated Podcast. The episode covers two articles written for DDW Volume 25, Issue 2, Spring 2024. The first article is called ‘Why more work is needed to fight antimicrobial resistance’. In the article, DDW Editor Reece Armstrong speaks to Professor… Read More

#Featured Podcasts

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

DDW Highlights: 18 November 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere,… Read More

#Podcasts

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

This week in Drug Discovery (10 – 14 November) 

News round-up for 10 – 14 November by Bruno Quinney, Content Team at DDW.  This week’s top story comes from groundbreaking research showing the Covid-19 mRNA vaccine boosts the immune system’s cancer response. The theme of UK investment dominates other headlines, while a report shows an effective… Read More

#News

Covid-19 vaccination
#Cancer research #Covid-19 vaccine #mRNA-based vaccines

Covid-19 mRNA vaccine boosts cancer response, study shows

Research showing the Covid-19 mRNA vaccine boosts the immune system’s response to cancer has been described as ‘extraordinary’.  Scientists at the University of Florida and the University of Texas MD Anderson Cancer Center found patients with advanced lung or skin cancer lived significantly longer when receiving the… Read More

#Cancer Research #Editor's Choice #News

Vaccine
#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA-based vaccines

The expanding market of vaccines  

By Stephen Adams, Associate Director, Optimum Strategic Communications  To say that vaccines and vaccine makers have been on a popularity rollercoaster in recent years is an understatement. Five years ago, with the world’s biotechs and pharma firms engaged in a high-stakes race to develop the first Covid vaccines, the mood… Read More

#Exclusive Content

#Immunology / Virology & Vaccines #Moderna #mRNA-based vaccines #Streptococcus #University of Queensland

Researchers step closer to a universal Strep-A mRNA vaccine

A team of microbiologists and immunologists has completed the first steps towards developing a universal vaccine against Group A Streptococcus (Strep-A).  The University of Queensland-led research in partnership with Moderna and published in Nature Communications has shown Strep-A can be successfully targeted using… Read More

#Editor's Choice #News

Vaccine production
#Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #United States

US cancels mRNA vaccine development contracts

The US Department of Health and Human Services (HHS) has announced the beginning of a “coordinated wind-down” of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).   The department says the decision follows a comprehensive review of mRNA-related investments initiated during the… Read More

#News #Trending News

mRNA
#Adaptvac #Immunology / Virology & Vaccines #mRNA #mRNA-based vaccines #University of Copenhagen

Virus-like particles enhance effect of mRNA vaccines

Researchers from Denmark have demonstrated that a simple addition to mRNA vaccines can significantly enhance their effectiveness.  mRNA technology is highly effective against viruses and quick to adapt to new variants, but the immunity tends to wane rapidly, leaving people vulnerable to reinfection just months after vaccination. Read More

#Editor's Choice #News

Influenza virus
#Collaboration #Ethris #Lonza #mRNA #mRNA-based vaccines #Respiratory

Partners develop non-invasive mRNA vaccines

Ethris and Lonza have announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates.  The vaccines are designed for mucosal delivery and offer a promising approach to combat respiratory diseases.  Room-temperature stability aims to address significant supply chain challenges associated with some… Read More

#News

European Union and African Union flags
#Biologics #Collaboration #Immunology / Virology & Vaccines #mRNA-based vaccines #RNA

African European alliance to advance RNA-based vaccines

A new African European collaboration aims to develop the first ever digital-to-biologics, end-to-end mRNA production platform, focusing on nucleic acid-based vaccines and therapeutics, including mRNA and saRNA vaccines.  A Memorandum of Understanding was signed by Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences during the… Read More

#News

DDW mRNA eBook cover
#eBook #mRNA #mRNA-based vaccines #RNA #tRNA

mRNA: Uses and innovation for this technology in drug discovery

This eBook, sponsored by Promega, examines the latest innovations that are driving the mRNA drug discovery and development market. Download this exclusive eBook to learn more about: Recent developments in mRNA drug discovery Using AI to design RNA-based medicines The evolution of the RNA therapeutics landscape Using tRNA to treat… Read More

#DDW eBooks #Intelligence